arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

cbdMD, Inc.

YCBD
$0.46 ▼ -0.03 (-6.67%) at close
Energy ·Perfumes, Cosmetics & Other Toilet Preparations ·USPerfumes, Cosmetics & Other Toilet Preparations
41 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

cbdMD, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.9M
Dividend Yield —
Revenue Growth 20.6% ↗
Op. Margin -20.4% ↘
ROIC -10.9% ↘
FCF / Share $-0.04 ↗
Trailing P/E —
Price / Book 0.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

41-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.55M
↑ +20.6% —
Net Income Profit after all expenses
$-1.13M
↓ -41.3% —
Operating Margin Operating profit as % of sales
-20.4%
↓ -43.4% 14th
FCF / Share Free cash flow per share
$-0.04
↑ +37.8% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
14
Returns ↓
24
Cash Quality ↑
54

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 41 quarters